Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial
Virus-Like Particles for Vaccine Development
Chimeric Virus-Like Particles as Vaccines
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial
Plant-produced virus-like particle vaccines